The Risk of Autoimmune Disorders in Treated Celiac Disease Patients in Olmsted County, Minnesota

Muhammad R. Khan, Shilpa S. Nellikkal, Ahmed Barazi, Joseph J. Larson, Joseph A Murray, Imad Absah

Research output: Contribution to journalArticle

Abstract

Background: Patients with autoimmune disorders (ADs) are at increased risk for celiac disease (CD), but data are conflicting on the risk of ADs in treated patients with CD. We aimed to assess the incidence of ADs in treated patients with CD. Methods: Using the Rochester Epidemiology Project, we retrospectively searched for the medical records at Mayo Clinic and Olmsted Medical Center from January 1997 to December 2015 for patients with CD who met accepted diagnostic criteria. For each patient with CD, we identified 2 age and sex-matched controls during the same study period. The incidence rate of AD diagnosis 5 years after index date was calculated using Kaplan-Meier analysis for the CD cases and controls and compared using the log-rank test. Results: We identified 249 treated patients with CD during the study period and 498 matched controls, with mean (standard deviation) ages of 32 (22) years and 33 (22) years, respectively. One third of patients (n = 85) and controls (n = 170) were boys. Five years after the index date, 5.0% of patients with CD and 1.3% of controls had a de novo AD diagnosis (P = 0.006). In the presence of a prior AD, the cumulative risk of a de novo or additional AD was significantly higher in the CD group compared with controls (P < 0.001). Children had a significantly higher risk of AD development compared with adults (P = 0.010). Conclusions: Treated patients with CD are at higher risk for the development of ADs. The risk of a new AD is higher in children, especially when >1 AD diagnosis exists.

Original languageEnglish (US)
Pages (from-to)438-442
Number of pages5
JournalJournal of pediatric gastroenterology and nutrition
Volume69
Issue number4
DOIs
StatePublished - Oct 1 2019

Fingerprint

Celiac Disease
Incidence
Kaplan-Meier Estimate
Medical Records
Epidemiology

Keywords

  • autoimmune disorders
  • celiac disease
  • children
  • endocrine
  • gluten

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Gastroenterology

Cite this

The Risk of Autoimmune Disorders in Treated Celiac Disease Patients in Olmsted County, Minnesota. / Khan, Muhammad R.; Nellikkal, Shilpa S.; Barazi, Ahmed; Larson, Joseph J.; Murray, Joseph A; Absah, Imad.

In: Journal of pediatric gastroenterology and nutrition, Vol. 69, No. 4, 01.10.2019, p. 438-442.

Research output: Contribution to journalArticle

Khan, Muhammad R. ; Nellikkal, Shilpa S. ; Barazi, Ahmed ; Larson, Joseph J. ; Murray, Joseph A ; Absah, Imad. / The Risk of Autoimmune Disorders in Treated Celiac Disease Patients in Olmsted County, Minnesota. In: Journal of pediatric gastroenterology and nutrition. 2019 ; Vol. 69, No. 4. pp. 438-442.
@article{36ea978d06b34f568303ab741dc8370f,
title = "The Risk of Autoimmune Disorders in Treated Celiac Disease Patients in Olmsted County, Minnesota",
abstract = "Background: Patients with autoimmune disorders (ADs) are at increased risk for celiac disease (CD), but data are conflicting on the risk of ADs in treated patients with CD. We aimed to assess the incidence of ADs in treated patients with CD. Methods: Using the Rochester Epidemiology Project, we retrospectively searched for the medical records at Mayo Clinic and Olmsted Medical Center from January 1997 to December 2015 for patients with CD who met accepted diagnostic criteria. For each patient with CD, we identified 2 age and sex-matched controls during the same study period. The incidence rate of AD diagnosis 5 years after index date was calculated using Kaplan-Meier analysis for the CD cases and controls and compared using the log-rank test. Results: We identified 249 treated patients with CD during the study period and 498 matched controls, with mean (standard deviation) ages of 32 (22) years and 33 (22) years, respectively. One third of patients (n = 85) and controls (n = 170) were boys. Five years after the index date, 5.0{\%} of patients with CD and 1.3{\%} of controls had a de novo AD diagnosis (P = 0.006). In the presence of a prior AD, the cumulative risk of a de novo or additional AD was significantly higher in the CD group compared with controls (P < 0.001). Children had a significantly higher risk of AD development compared with adults (P = 0.010). Conclusions: Treated patients with CD are at higher risk for the development of ADs. The risk of a new AD is higher in children, especially when >1 AD diagnosis exists.",
keywords = "autoimmune disorders, celiac disease, children, endocrine, gluten",
author = "Khan, {Muhammad R.} and Nellikkal, {Shilpa S.} and Ahmed Barazi and Larson, {Joseph J.} and Murray, {Joseph A} and Imad Absah",
year = "2019",
month = "10",
day = "1",
doi = "10.1097/MPG.0000000000002418",
language = "English (US)",
volume = "69",
pages = "438--442",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The Risk of Autoimmune Disorders in Treated Celiac Disease Patients in Olmsted County, Minnesota

AU - Khan, Muhammad R.

AU - Nellikkal, Shilpa S.

AU - Barazi, Ahmed

AU - Larson, Joseph J.

AU - Murray, Joseph A

AU - Absah, Imad

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Background: Patients with autoimmune disorders (ADs) are at increased risk for celiac disease (CD), but data are conflicting on the risk of ADs in treated patients with CD. We aimed to assess the incidence of ADs in treated patients with CD. Methods: Using the Rochester Epidemiology Project, we retrospectively searched for the medical records at Mayo Clinic and Olmsted Medical Center from January 1997 to December 2015 for patients with CD who met accepted diagnostic criteria. For each patient with CD, we identified 2 age and sex-matched controls during the same study period. The incidence rate of AD diagnosis 5 years after index date was calculated using Kaplan-Meier analysis for the CD cases and controls and compared using the log-rank test. Results: We identified 249 treated patients with CD during the study period and 498 matched controls, with mean (standard deviation) ages of 32 (22) years and 33 (22) years, respectively. One third of patients (n = 85) and controls (n = 170) were boys. Five years after the index date, 5.0% of patients with CD and 1.3% of controls had a de novo AD diagnosis (P = 0.006). In the presence of a prior AD, the cumulative risk of a de novo or additional AD was significantly higher in the CD group compared with controls (P < 0.001). Children had a significantly higher risk of AD development compared with adults (P = 0.010). Conclusions: Treated patients with CD are at higher risk for the development of ADs. The risk of a new AD is higher in children, especially when >1 AD diagnosis exists.

AB - Background: Patients with autoimmune disorders (ADs) are at increased risk for celiac disease (CD), but data are conflicting on the risk of ADs in treated patients with CD. We aimed to assess the incidence of ADs in treated patients with CD. Methods: Using the Rochester Epidemiology Project, we retrospectively searched for the medical records at Mayo Clinic and Olmsted Medical Center from January 1997 to December 2015 for patients with CD who met accepted diagnostic criteria. For each patient with CD, we identified 2 age and sex-matched controls during the same study period. The incidence rate of AD diagnosis 5 years after index date was calculated using Kaplan-Meier analysis for the CD cases and controls and compared using the log-rank test. Results: We identified 249 treated patients with CD during the study period and 498 matched controls, with mean (standard deviation) ages of 32 (22) years and 33 (22) years, respectively. One third of patients (n = 85) and controls (n = 170) were boys. Five years after the index date, 5.0% of patients with CD and 1.3% of controls had a de novo AD diagnosis (P = 0.006). In the presence of a prior AD, the cumulative risk of a de novo or additional AD was significantly higher in the CD group compared with controls (P < 0.001). Children had a significantly higher risk of AD development compared with adults (P = 0.010). Conclusions: Treated patients with CD are at higher risk for the development of ADs. The risk of a new AD is higher in children, especially when >1 AD diagnosis exists.

KW - autoimmune disorders

KW - celiac disease

KW - children

KW - endocrine

KW - gluten

UR - http://www.scopus.com/inward/record.url?scp=85072196233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072196233&partnerID=8YFLogxK

U2 - 10.1097/MPG.0000000000002418

DO - 10.1097/MPG.0000000000002418

M3 - Article

C2 - 31219935

AN - SCOPUS:85072196233

VL - 69

SP - 438

EP - 442

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 4

ER -